Thermo Fisher Scientific develops COVID-19 antibody assay targeting transplant community
This powerful new solution aims to provide more accurate COVID-19 antibody detection
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer
Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time
New assays for Campylobacter, STEC, Vibrio and Staphylococcus aureus enable more comprehensive pathogen testing for all food manufacturers
Dr. Clifton Ray discusses the potential of Nanotrap particles to advance extracellular vesicle research, and how his team is using them to break down barriers in isolation, screening, and disease diagnostics
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab
Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers
Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility
The panel will be bundled with an analysis platform from One Codex designed to enable an easy-to-use, complete end-to-end workflow that begins from the Twist target enrichment panel and continues through publication-ready visualizations
Researchers suggest cortisol levels can be used to identify those patients who are more likely to need intensive care
Download this application note from Sartorius to discover how the need to monitor T cell phenotype and function for improved T cell expansion protocols was addressed with a T cell memory cell and cytokine profiling assay
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Join this webinar to find out how scientists are detecting the antibodies blocking viral entry into the cell
New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin
Dr. Fang Xie shares insights from his research into prostate cancer and offers hope of overcoming the growing problem of chemotherapy resistance to improve patient outcomes
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
We speak with Dr. John Abbenante about how application-based content can help optimize your assays, whatever your research area